March 25, 2010.
UK Prime Minister Gordon Brown has pledged to appoint a Minister for Life Sciences to co-ordinate research and commercial activity in the sector. The move follows what has been seen as a successful start by the Office of Life Sciences (OLS), established by the government in January last year; progressive OLS initiatives have included the Innovation Pass, the UK Innovation Investment Fund and the Strategic Health Authority Innovation Board. It is thought that the new minister will be a scientist rather than a 'politician'.
In a joint statement, the UK's four life sciences trade associations - the Association for the British Healthcare Industry, the Association for the British Pharmaceutical Industry, the BioIndustry Association and the British In Vitro Diagnostics Association - welcomed the move, commenting: "[This] is further recognition of the vital role our industry plays in the health of the nation and in its economic well-being ... Supporting the UK's science and innovation base must be a priority for any future government. The UK must send a clear message to the rest of the world that it is - and is determined to remain - a world leader in the field of life sciences."
IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment
August 20th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.